Clinical Data Disclosure: PhRMA Principles Rely On Review Boards To Screen Research Proposals

PhRMA and EFPIA issue joint principles that urge firms to release the synopses of clinical study reports; PhRMA objects to FDA’s proposal to release masked, de-identified data on the grounds of patient privacy, competitive secrecy.